文献速递产科

剖宫产中使用氨甲环酸:用药错误导致的死亡

Tranexamic acid at cesarean delivery: drug-error deaths.
PubMed 文献 · BJOG · 2022-10-27

氨甲环酸用于产后出血已在全球产科实践中应用,但近期发生多起误将氨甲环酸代替局部麻醉药用于脊髓麻醉的病例,其神经毒性可致快速发作的惊厥,死亡率达50%。美国食品药品监督管理局和世界卫生组织已发布药物安全警示,但作者认为仍不足,建议广泛传播信息提高认知,并制定医院本地规程确保氨甲环酸与麻醉药物分开存放,最好存放在手术室外并附有辅助警告标签。

要点

  • 误将氨甲环酸用于脊髓麻醉可致快速发作的惊厥,死亡率达50%。
  • 美国食品药品监督管理局和世界卫生组织已发布药物安全警示。
  • 作者建议广泛传播信息并制定医院规程,确保氨甲环酸与麻醉药物分开存放。

核心结论

  • 氨甲环酸误用于脊髓麻醉的灾难性错误报告例数似在增加,需大规模实施安全策略以确保其挽救生命的潜力不被用药错误导致的死亡所掩盖。

研究设计与样本

  • 原文为评论文章,未报告系统检索范围或样本量。

主要发现

  • 近期发现多起误将氨甲环酸代替局部麻醉药用于脊髓麻醉的病例。
  • 氨甲环酸的深度神经毒性导致快速发作的惊厥,死亡率达50%。

关键数值与推荐

  • 美国食品药品监督管理局和世界卫生组织已发布药物安全警示。
  • 作者建议广泛传播信息以提高对这一潜在危害的认识。
  • 作者建议制定医院本地规程,确保氨甲环酸与麻醉药物分开存放,最好存放在手术室外并附有辅助警告标签。

临床怎么用

  • 作者建议广泛传播信息以提高对氨甲环酸误用于脊髓麻醉这一潜在危害的认识。
  • 作者建议制定医院本地规程,确保氨甲环酸与麻醉药物分开存放,最好存放在手术室外并附有辅助警告标签。
  • 作者认为需大规模实施安全策略,以确保氨甲环酸挽救生命的潜力不被用药错误导致的死亡所掩盖。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The use of tranexamic acid for postpartum hemorrhage has entered obstetrical practice globally with the evidence-based expectation of saving lives. This improvement in the care of women with postpartum hemorrhage has come at a price. For the anesthetist, having tranexamic acid ampoules close at hand would seem an obvious strategy to facilitate its use during cesarean delivery, an important setting for severe hemorrhage. Tragically, we have identified a number of recent instances of inadvertent intrathecal administration of tranexamic acid instead of local anesthetic for spinal anesthesia. Reported cases of this catastrophic error seem to be increasing. The profound neurotoxicity of tranexamic acid causes rapid-onset convulsions, with mortality of 50%. How can these tragic errors be averted? Drug safety alerts have been issued by the US Food and Drug Administration and the World Health Organization, but that is not enough. We recommend extensive dissemination of information to raise awareness of this potential hazard, and local hospital protocols to ensure that tranexamic acid is stored separately from anesthetic drugs, preferably outside the operating room and with an auxiliary warning label. Implementation of safety strategies on a very large scale will be needed to ensure that the life-saving potential of tranexamic acid is not eclipsed by drug-error mortality.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Moran NF, Bishop DG, Fawcus S, et al. Tranexamic acid at cesarean delivery: drug-error deaths. BJOG. 2022. PMID: 36300729. doi:10.1111/1471-0528.17292

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。